| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/05/2008 | CA2668808A1 (s)-phenyl(heterocycle)methanol-based compounds, compositions comprising them and methods of their use |
| 06/05/2008 | CA2668713A1 Novel phenyl-isoxazol-3-ol derivative |
| 06/05/2008 | CA2668579A1 Cis-cyclohexyl substituted pyrimidinone derivatives |
| 06/05/2008 | CA2668124A1 5-[(2r)-[2-[2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethyl]amino]propyl]-2-methoxybenzenesulfonamide |
| 06/05/2008 | CA2667846A1 Substituted pyrazoles, compositions containing these, method of production and use |
| 06/05/2008 | CA2666564A1 Formulations for treatment of adipose tissue, cutaneous tissue and disorders, and muscular tissue |
| 06/05/2008 | CA2666365A1 Topical avermectin formulations and methods for elimination and prophylaxis of susceptible and treatment-resistant strains of head lice |
| 06/05/2008 | CA2665226A1 Novel formulations of proton pump inhibitors and methods of using these formulations |
| 06/05/2008 | CA2663618A1 Azole nucleosides and use as inhibitors of rna and dna viral polymerases |
| 06/04/2008 | WO2008068923A1 Nucleic acid-degrading agent and method for degradation of nucleic acid |
| 06/04/2008 | EP1927665A2 Methods and kits for diagnosing and treating b-Cell chronic lymphocytic leukemia (B-CLL) |
| 06/04/2008 | EP1927660A2 Methods for delivering DNA to muscle cells using recombinant adeno-associated virus virions |
| 06/04/2008 | EP1927595A2 Salts of clopidogrel and process for preparation |
| 06/04/2008 | EP1927594A1 1,2,3-Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia |
| 06/04/2008 | EP1927591A1 Polymorphic Forms of Deferasirox (ICL670) |
| 06/04/2008 | EP1927589A1 Quinoline derivatives |
| 06/04/2008 | EP1927378A1 Hair-treatment compositions comprising quercetin and use thereof to revitalize hair |
| 06/04/2008 | EP1927368A2 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
| 06/04/2008 | EP1927366A1 Combination vaccine against streptococcus pneumoniae and respiratory syncytial virus (RSV) |
| 06/04/2008 | EP1927361A1 Visceral fat accumulation inhibitor |
| 06/04/2008 | EP1927360A1 Visceral fat accumulation inhibitor |
| 06/04/2008 | EP1927359A2 2-Methoxyestradiol for the treatment of inflammatory disorders |
| 06/04/2008 | EP1927358A1 Sustained-release preparation |
| 06/04/2008 | EP1927357A2 Low hygroscopic aripiprazole (crystal E) drug substance and processes for the preparation thereof |
| 06/04/2008 | EP1927356A1 Low hygroscopic aripiprazole (crystal D) drug substance and processes for the preparation thereof |
| 06/04/2008 | EP1927355A1 Low hygroscopic aripiprazole (crystal F) drug substance and processes for the preparation thereof |
| 06/04/2008 | EP1927354A1 Novel substituted benzimidazole dosage forms and method of using same |
| 06/04/2008 | EP1927353A1 Remedy for corneal diseases |
| 06/04/2008 | EP1927352A2 Therapeutic methods and compositions involving isoflavones |
| 06/04/2008 | EP1927351A1 Use of agomelatine to obtain medication aimed at treating periventricular leukomalacia |
| 06/04/2008 | EP1927350A1 Methods for improving bioavailability of a renin inhibitor |
| 06/04/2008 | EP1927349A1 Composition for life extension and method of extending the life |
| 06/04/2008 | EP1927348A1 Anticonvulsive pharmaceutical compositions |
| 06/04/2008 | EP1927292A1 Synergism of GOS and polyfructose |
| 06/04/2008 | EP1926768A1 Method for preparing branched functionalized polymers using branched polyol cores |
| 06/04/2008 | EP1926750A2 Biological materials and uses thereof |
| 06/04/2008 | EP1926737A1 4-amino-thieno[3,2-c]pyridine-7-carboxylic acid derivatives |
| 06/04/2008 | EP1926736A1 Novel resinate complex of s-clopidogrel and production method thereof |
| 06/04/2008 | EP1926735A1 Tetracyclic inhibitors of janus kinases |
| 06/04/2008 | EP1926734A1 Pyrazolopyridine and pyrazolopyrimidine compounds useful as kinase enzymes modulators |
| 06/04/2008 | EP1926733A2 Tetracyclic indole derivatives as antiviral agents |
| 06/04/2008 | EP1926731A2 Amino-aza-adamantane derivatives and methods of use |
| 06/04/2008 | EP1926730A1 Novel diazaspiroalkanes and their use for treatment of ccr8 mediated diseases |
| 06/04/2008 | EP1926729A1 Benzothiazole cyclobutyl amine derivatives and their use as histamine-3 receptors ligands |
| 06/04/2008 | EP1926727A1 4-chromenonyl-1,4-dihydropyridinecarbonitriles and the use thereof |
| 06/04/2008 | EP1926726A2 Non-fluorescent chlorophyll catabolites |
| 06/04/2008 | EP1926725A1 Alkoxy indolinone based protein kinase inhibitors |
| 06/04/2008 | EP1926724A1 Analogs of dehydrophenylahistins and their therapeutic use |
| 06/04/2008 | EP1926723A2 Azabicyclo (3,1,0) hexan derivatives useful as modulators of dopamine d3 rceptors |
| 06/04/2008 | EP1926722A1 Substituted benzimidazoles as kinase inhibitors |
| 06/04/2008 | EP1926721A2 Thiophene and thiazole substituted trifluoroethanone derivatives as histone deacetylase (hdac) inhibitors |
| 06/04/2008 | EP1926720A1 CRYSTALLINE FORMS OF 1-CHLORO-4-(ß-D-GLUCOPYRANOS-1-YL)-2-(4-ETHYNYL-BENZYL)-BENZENE, METHODS FOR ITS PREPARATION AND THE USE THEREOF FOR PREPARING MEDICAMENTS |
| 06/04/2008 | EP1926719A2 2-aniline-4-aryl substituted thiazole derivatives |
| 06/04/2008 | EP1926714A1 Isotopically substituted benzimidazole derivatives |
| 06/04/2008 | EP1926712A1 6-substituted 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists |
| 06/04/2008 | EP1926708A1 Biaryl substituted heterocycle inhibitors of lta4h for treating inflammation |
| 06/04/2008 | EP1926705A2 Process for preparing valsartan |
| 06/04/2008 | EP1926500A2 Methods of making radiolabeled tracers and precursors thereof |
| 06/04/2008 | EP1926499A1 Use of therapeutically active lipids together with method of producing organ/tissue-specific therapeutically active lipids |
| 06/04/2008 | EP1926490A2 Use of opioid receptor antagonists |
| 06/04/2008 | EP1926489A2 Liposomes for treatment of multiple myeloma |
| 06/04/2008 | EP1926488A2 Combination of rosiglitazone and donepezil for improvement of cognitive function |
| 06/04/2008 | EP1926487A2 Thiazolidinone amides, thiazolidine carboxylic acid amides, and serine amides, including polyamine conjugates thereof, as selective anti-cancer agents |
| 06/04/2008 | EP1926486A1 Novel polymorphs of (s)-2,6-diamino-4,5,6,7-tetrahydrobenzothiazole monotartrate and methods of producing and using the same |
| 06/04/2008 | EP1926485A2 Hif inhibitors |
| 06/04/2008 | EP1926484A2 Depigmenting composition for the skin, comprising adapalene, at least one depigmenting agent and at least one anti-inflammatory agent |
| 06/04/2008 | EP1926483A2 Treatment of autoimmune diseases |
| 06/04/2008 | EP1926482A2 Pharmaceutical form with sustained ph-independent active ingredient release for active ingredients having strong ph-dependent solubility |
| 06/04/2008 | EP1926481A2 Highly concentrated pourable aqueous solutions of potassium ibuprofen their preparation and their uses |
| 06/04/2008 | EP1926479A2 Drug compositions containing controlled release hypromellose matrices |
| 06/04/2008 | EP1926477A1 Composition comprising a nsaid and paracetamol |
| 06/04/2008 | EP1926476A2 Amorphous solid dispersions of 7-chloro-n,n, 5-trimethyl-4-oxo-3-phenyl-3, 5,-dihydro-4h-pyridazino[4,5-b]indole-1-acetamide |
| 06/04/2008 | EP1926473A2 Antimicrobial preparations having a content of octenidine dihydrochloride encapsulated in liposomes |
| 06/04/2008 | EP1926472A2 Stabilized and preserved ketotifen ophthalmic compositions |
| 06/04/2008 | EP1926391A1 Combination of bioavailable methionine with at least one essential oil |
| 06/04/2008 | EP1926372A2 HUMAN RIBOSOMAL DNA(rDNA) AND RIBOSOMAL RNA (rRNA) NUCLEIC ACIDS AND USES THEREOF |
| 06/04/2008 | EP1828131B1 Piperidinesulfonylureas and -thioureas, their preparation, their use and pharmaceutical compositions comprising them |
| 06/04/2008 | EP1756086B1 Pyridin-4-yl-ethynyl-imidazoles and pyrazoles as mglu5 receptor antagonists |
| 06/04/2008 | EP1747198B1 Adamantyl pyrrolidin-2-one derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 06/04/2008 | EP1737847B1 Nebivolol and its pharmaceutically acceptable salts, process for preparation and pharmaceutical compositions of nebivolol |
| 06/04/2008 | EP1663952B1 Abiotic heparin antagonists |
| 06/04/2008 | EP1660107A4 A ginseng preparation using vinegar and process for thereof |
| 06/04/2008 | EP1648483B1 Composition for treating and/or preventing insulin resistance |
| 06/04/2008 | EP1611139B1 Methods of preparing olanzapine |
| 06/04/2008 | EP1592687B1 Benzofurane derivatives and the use of the same as antidepressants and anxiolytics |
| 06/04/2008 | EP1562566B1 Analgesic compositions comprising nmda receptor antagonists and benzalkonium chloride |
| 06/04/2008 | EP1532134B1 Novel thiophene acyl hydrazino derivatives, method for preparing same, use thereof as medicines, pharmaceutical compositions and novel use |
| 06/04/2008 | EP1487817B1 Piperidine derivatives useful as modulators of chemokine receptor activity |
| 06/04/2008 | EP1478339B1 Pharmaceutical formulations of antineoplastic agents, in particular temozolomide, processes of making and using the same |
| 06/04/2008 | EP1474119B1 Use of extracts containing phytoestrogen selectively modulating estrogen-receptor-beta |
| 06/04/2008 | EP1469853B1 Use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno(2,3-d-pyrimidine for treating of urinary incontinence |
| 06/04/2008 | EP1456357B1 Pluripotent embryonic-like stem cells derived from teeth and uses thereof |
| 06/04/2008 | EP1448089A4 Devices and methods for the restoration of a spinal disc |
| 06/04/2008 | EP1395591B1 Corticotropin releasing factor antagonists |
| 06/04/2008 | EP1392688B1 Pyrazino[1',2':1,6]-pyrido[3,4-b] indole-1,4-dione derivatives |
| 06/04/2008 | EP1377316B1 Pharmaceutical composition based on azalides for topical application in ophthalmology |
| 06/04/2008 | EP1365781B1 Acrochordon alleviation |
| 06/04/2008 | EP1345954B1 Methods utilizing aryl thioimines in synthesis of erythromycin derivatives |
| 06/04/2008 | EP1343775B1 Piperazine derivatives |
| 06/04/2008 | EP1339669B1 N-alkylated gaba compounds, processes for their preparation and their use as medicaments |